Standout Papers

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG... 2011 2026 2016 2021 784
  1. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies (2011)
    Daniel A. Winer, Shawn Winer et al. Nature Medicine
  2. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy (2024)
    Mark Hamilton, Takeshi Sugio et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 17 from Science/Nature 68 standout
Sub-graph 1 of 18

Citing Papers

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2025 Standout
1 intermediate paper

Works of David B. Miklos being referenced

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
2024 Standout
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7
2024
and 3 more

Author Peers

Author Last Decade Papers Cites
David B. Miklos 2115 2532 2046 216 6.3k
Frederic I. Preffer 2001 2258 1550 112 6.9k
Judith A. Shizuru 2108 3682 3563 175 7.9k
Arjan C. Lankester 2096 2930 2650 229 7.6k
Hans‐Jochem Kolb 1689 1821 3155 172 5.8k
Avichai Shimoni 2840 2035 3485 249 6.7k
Jennifer M. McNiff 1903 3535 2099 198 7.6k
S Slavin 1186 2437 3025 184 5.6k
Richard A. Nash 1529 2703 4839 175 7.7k
Joseph W. Fay 2261 3612 1718 106 6.2k
JH Kersey 1868 2803 4447 109 7.5k

All Works

Loading papers...

Rankless by CCL
2026